Literature DB >> 3118258

Genetic polymorphism of C3 and Bf in IgA nephropathy.

M Rambausek1, A W van den Wall Bake, R Schumacher-Ach, R Spitzenberg, U Rother, L A van Es, E Ritz.   

Abstract

C3 and Bf alleles were examined in the general population, in 67 patients with biopsy-confirmed mesangial IgA nephropathy and 81 patients with other types of glomerulonephritis, from the Heidelberg and Leiden renal programmes respectively. In both populations, a significant excess of homozygous phenotype C3FF (3.4% in controls; 10.4% in IgA nephropathy) and a deficit of C3FS heterozygous phenotype (35.8% in controls; 19.4% in IgA nephropathy) were observed in patients with IgA nephropathy, but not in other types of glomerulonephritis. No difference of C3 gene frequencies was found. C3FF was associated with an adverse clinical outcome (a higher prevalence of renal failure and hypertension). A significant excess of Bf-F gene frequency was noted (0.20 in controls; 0.33 in IgA nephropathy). In addition, an excess of phenotype BfFF was found (none in controls; 10.4% in IgA nephropathy). BfFF homozygotes also carried a higher risk of an adverse outcome (renal failure and hypertension). The data suggest a role for genetically coded (presumably) immunological factors in the genesis and course of IgA nephropathy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3118258

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  17 in total

1.  Can one predict the prognosis in patients with IgA nephropathy from the analysis of serum complement?

Authors:  R J Wyatt
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

2.  Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk.

Authors:  Meike Heurich; Ruben Martínez-Barricarte; Nigel J Francis; Dawn L Roberts; Santiago Rodríguez de Córdoba; B Paul Morgan; Claire L Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

Review 3.  Complement, age-related macular degeneration and a vision of the future.

Authors:  Karen M Gehrs; Jared R Jackson; Eric N Brown; Rando Allikmets; Gregory S Hageman
Journal:  Arch Ophthalmol       Date:  2010-03

4.  Molecular analysis of C3 allotypes in patients with nephritic factor.

Authors:  J E Finn; P W Mathieson
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

5.  The investigation of allele and genotype frequencies of human C3 (rs2230199) in south Iranian population.

Authors:  Najmeh Bazyar; Negar Azarpira; Saied Reza Khatami; Hamid Galehdari
Journal:  Mol Biol Rep       Date:  2012-06-21       Impact factor: 2.316

6.  Polymorphisms in complement component 3 (C3F) and complement factor H (Y402H) increase the risk of postoperative neurocognitive dysfunction following carotid endarterectomy.

Authors:  Paul R Gigante; Ivan S Kotchetkov; Christopher P Kellner; Raqeeb Haque; Andrew F Ducruet; Brian Y Hwang; Robert A Solomon; Eric J Heyer; E Sander Connolly
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-09-14       Impact factor: 10.154

7.  The complex nature of serum C3 and C4 as biomarkers of lupus renal flare.

Authors:  D J Birmingham; F Irshaid; H N Nagaraja; X Zou; B P Tsao; H Wu; C Y Yu; L A Hebert; B H Rovin
Journal:  Lupus       Date:  2010-07-06       Impact factor: 2.911

8.  R102G polymorphism of the C3 gene associated with exudative age-related macular degeneration in a French population.

Authors:  Jennyfer Zerbib; Florence Richard; Nathalie Puche; Nicolas Leveziel; Salomon Y Cohen; Jean-François Korobelnik; José Sahel; Arnold Munnich; Josseline Kaplan; Jean-Michel Rozet; Eric H Souied
Journal:  Mol Vis       Date:  2010-07-15       Impact factor: 2.367

Review 9.  The role of the alternative pathway of complement activation in glomerular diseases.

Authors:  Emilia Łukawska; Magdalena Polcyn-Adamczak; Zofia I Niemir
Journal:  Clin Exp Med       Date:  2018-02-15       Impact factor: 3.984

10.  Polymorphism of the complement receptor 1 gene correlates with the hematologic response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Tommaso Rondelli; Antonio M Risitano; Régis Peffault de Latour; Michela Sica; Benedetta Peruzzi; Patrizia Ricci; Wilma Barcellini; Anna Paola Iori; Carla Boschetti; Veronica Valle; Veronique Frémeaux-Bacchi; Maria De Angioletti; Gerard Socie; Lucio Luzzatto; Rosario Notaro
Journal:  Haematologica       Date:  2013-09-13       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.